Data Collective IV GP, LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Data Collective IV GP, LLC reported 5 stock positions worth $115.3 million. Its top holding was Recursion Pharmaceuticals-A (RXRX) at 51.4% of the portfolio, followed by Evolv Technologies (EVLV, 37.4%) and Rocket Lab USA (RKLB, 10.4%). Its holdings were unchanged from Q4 2023.
- Most Recent 13F
- Q2 2026
- Location
- PALO ALTO, CA
- CIK
- 0001664974
- Portfolio Value
- $115.3M (Q1 2024)
- SEC Filing
- 0001104659-24-061601 ↗ filed May 15, 2024
Holdings Value
Holdings 5 stocks · $115.3M
| RXRX Recursion Pharmaceuticals-A | 51.36% | 5,941,120 | $59.2M | No change |
| EVLV Evolv Technologies Holdings | 37.35% | 9,681,281 | $43.1M | No change |
| RKLB Rocket Lab USA Inc. | 10.44% | 2,929,350 | $12.0M | No change |
| MIND MEDICINE MINDMED INC | 0.82% | 100,350 | $943K | No change |
| ROIV Roivant Sciences Ltd. | 0.04% | 3,875 | $41K | No change |
Portfolio Sells Q4 2023 → Q1 2024
| None this quarter. | |||
Portfolio Buys Q4 2023 → Q1 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 4 | $78.6M | EVLV, HQ, RXRX, DFTX |
| Q1 2026 | 4 | $55.9M | EVLV, RXRX, HQ, DFTX |
| Q4 2025 | 3 | $58.5M | EVLV, RXRX, MIND MEDICINE MINDMED INC |
| Q3 2025 | 4 | $68.0M | EVLV, RXRX, MIND MEDICINE MINDMED INC, ROIV |
| Q2 2025 | 5 | $129.9M | EVLV, RKLB, RXRX, MIND MEDICINE MINDMED INC, ROIV |
| Q1 2025 | 5 | $86.9M | RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC, ROIV |
| Q4 2024 | 6 | $226.3M | OKLO, RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC |
| Q3 2024 | 6 | $163.5M | OKLO, EVLV, RXRX, RKLB, MIND MEDICINE MINDMED INC |
| Q2 2024 | 6 | $142.7M | OKLO, RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC |
| Q1 2024 | 5 | $115.3M | RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC, ROIV |